Efficacy and safety of the sofosbuvir/velpatasvir combination for the treatment of patients with early mild to moderate COVID-19

SARS-CoV-2 is still a health problem worldwide despite the availability of vaccines. Therefore, there is a need for effective and safe antiviral. SARS-CoV-2 and HCV necessitate RNA-dependent RNA polymerase (RdRp) for replication; therefore, it has been hypothesized that RdRp inhibitors used to treat...

Descripción completa

Detalles Bibliográficos
Autores principales: Messina, Vincenzo, Nevola, Riccardo, Izzi, Antonio, De Lucia Sposito, Pellegrino, Marrone, Aldo, Rega, Roberto, Fusco, Raffaele, Lumino, Paolina, Rinaldi, Luca, Gaglione, Pasqualina, Simeone, Filomena, Sasso, Ferdinando Carlo, Maggi, Paolo, Adinolfi, Luigi Elio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8985058/
https://www.ncbi.nlm.nih.gov/pubmed/35388092
http://dx.doi.org/10.1038/s41598-022-09741-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8985058/
https://www.ncbi.nlm.nih.gov/pubmed/35388092
http://dx.doi.org/10.1038/s41598-022-09741-5

Ejemplares similares